Related Experiment Videos
Erythroid toxicity of azathioprin. Macrocytosis and selective marrow hypoplasis
Abstract:
In a population of 70 stable renal allograft recipients receiving azathioprine, macrocytosis was present in a majority and its severity was related to azathioprine dosage. There were associated megaloblastoid marrow changes which could not be related to serum folate or vitamin B12 concentrations. Two cases of selective red cell hypoplasia in renal allograft recipients are described; in each patient, azathioprine was incriminated and the effect dose-related. These observations indicate that the erythroid effects of azathioprine may precede, and be independent of, its effects on the myeloid series.
Insights
Azathioprine can cause red blood cell issues, like macrocytosis and hypoplasia, in kidney transplant patients. These effects are dose-dependent and may occur before myeloid problems, impacting erythroid health.
Area of Science:
- Nephrology
- Hematology
- Immunosuppression
Background:
- Azathioprine is a common immunosuppressant used in renal transplant recipients.
- Understanding its potential side effects on hematopoiesis is crucial for patient management.
Purpose of the Study:
- To investigate the erythroid effects of azathioprine in stable renal allograft recipients.
- To determine the relationship between azathioprine dosage and hematological changes.
Main Methods:
- Observational study of 70 stable renal allograft recipients on azathioprine.
- Analysis of hematological parameters, including red blood cell indices and bone marrow morphology.
- Correlation of findings with azathioprine dosage, serum folate, and vitamin B12 levels.
Main Results:
- A majority of patients exhibited macrocytosis, with severity correlated to azathioprine dosage.
- Megaloblastoid marrow changes were observed, independent of folate or vitamin B12 levels.
- Two cases of selective red cell hypoplasia were identified, with azathioprine implicated in a dose-dependent manner.
Conclusions:
- Azathioprine can induce significant erythroid abnormalities in renal transplant recipients.
- The observed erythroid effects may manifest independently of, and prior to, myeloid-related side effects.
- Careful monitoring of hematological parameters is essential in patients receiving azathioprine therapy.